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Letter to the EditorAntibody-encoding repertoires of
bonemarrow and peripheral blood—
a focus on IgETo the Editor:
Allergic responses are initiated by the interaction between
antigen and IgEs carried on effector cells such as mast cells and
basophils. However, the detailed molecular nature of IgE is not
amendable to analysis using many of the most commonly used
methodologies because B cells/plasma cells that produce them are
scarce. Lately, next-generation sequencing (NGS) has allowed us
to analyze immunoglobulin-encoding genes at a rate unimagin-
able in the past.1 Although such investigations tend to focus on
antibody repertoires other than IgE, the technology has already
enhanced our understanding of IgE responses in allergic disease
(see Table E1 in this article’s Online Repository at www.
jacionline.org). Many antibody sequencing studies focus on rep-
ertoires encoded by cells in peripheral blood (PB), a readily avail-
able source of antibody-producing cells. However, studies have
defined differences between repertoires of immunoglobulin-
encoding genes of PB and those encoded in various immunolog-
ically active tissues.2 Furthermore, a recent study demonstrated
that IgE produced by cells in PB poorly represented circulating
IgE.3 In all, because much IgE is produced by cells localized to
tissues beyond PB, analysis of this disease-causing isotype is
lacking in breadth and relevance.
To address the nature of immunoglobulin repertoires, including
IgE, at a site readily available for analysis (PB) and at a major site
of antibody production (bone marrow [BM]), we have now
examined the immunoglobulin heavy chain repertoire, a major
carrier of antibody specificity,4 encoded by cells residing at these
sites. Samples were collected from 6 allergic subjects in
biological duplicates so as to specifically allow analysis of the
IgE repertoire in subjects in whom it actually inflicts disease.
These subjects (see Table E2 in this article’s Online Repository
at www.jacionline.org) suffered from allergic rhinitis but had
not undergone specific immunotherapy (SIT). Samples were
collected out of season of most seasonal allergens, but stimulation
with perennial allergens around the time of sample collection
cannot be excluded. At the time of sample collection, these
subjects, though, had no symptoms of an ongoing allergic
response. Sequencing (MiSeq Technology; Illumina, Inc, San
Diego, Calif) and analysis were performed as outlined in the
Methods section in the Online Repository at www.jacionline.
org (see also Tables E3 and E4 and Figs E1 and E2 in this article’s
Online Repository at www.jacionline.org).
Sequence analysis revealed a large number of clones derived
from a diversity of germline genes. Repertoires of IgA, IgG, and
IgM of BM and PB showed very similar composition in terms of
IGHV gene, IGHJ gene, and IGHD subgroup usage, and CDRH3
length distributions (see Tables E5 and E6 and Figs E3-E6 in this
article’s Online Repository at www.jacionline.org). IgA, IgG,
and IgM repertoires in BM were more mutated than their
corresponding repertoires encoded in PB (see Figs E7 and E8 in 2016 The Authors. Published by Elsevier, Inc. on behalf of the American Academy of
Allergy, Asthma & Immunology. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).this article’s Online Repository at www.jacionline.org). Analysis
of duplicated samples of BM and PB demonstrated an appreciable
degree of reproducibility in terms of overlap in these samples’
description of the IgA, IgG, and IgM repertoires (Fig 1, C; see
Tables E5 and E6 and Figs E3 and E5). Furthermore, a substantial
clonal overlap was identified between samples obtained from
BM and PB (Fig 2). Both sample types thus appeared to
adequately describe a sizable fraction of the available repertoires.
Furthermore, a small but detectable fraction of clones from IgA
and IgG repertoires, in particular, were also detected in other
isotypes’ repertoires (except IgE) (Fig 2).
In stark contrast to the reproducibility of IgA, IgG, and IgM
repertoires of BM and PB, we found that samples of PB of a
commonly available volume (10 mL) did not adequately
describe the IgE repertoire. Very few, entirely different
rearrangements were in general found in biological duplicate
samples. The sequences’ germline gene origin and the length of
their encoded third hypervariable loop differed dramatically,
and 1 of 6 donors lacked amplifiable IgE-encoding
rearrangements in PB altogether. In contrast, the IgE-encoding
repertoires found in duplicate BM samples were larger in size,
reproducible in composition, and more diverse in terms of
germline gene usage and length of the encoded third
hypervariable loop (Fig 1; see Tables E5 and E6 and Figs E3
and E9 in this article’s Online Repository at www.jacionline.
org). Clonally diversified sequences were identified among these
sequences (see Fig E10 in this article’s Online Repository at
www.jacionline.org). However, irrespective of tissue origin,
clustering analysis of transcript populations largely failed to
associate IgE-encoding transcript populations to the donor’s
transcriptomes encoding other isotypes (Figs 1, C, and 2),
suggesting that IgE’s clonal origin is to a large degree different
from those of other isotypes. In summary, IgE repertoires of BM
samples are more diverse than their corresponding PB samples.
Individual PB samples of a commonly available size not only
poorly describe the IgE-encoding transcriptome but also
substantially underestimate the diversity of IgE encoded by
transcriptomes in BM, a major site of antibody production.
IgE-encoding transcriptomes defined in PB must consequently
be used with caution in studies of IgE.
Antigen-specific IgG4 is an antibody associatedwith prevention
of allergic reactions.5 All 6 donors produced IgG4 (see Table E2).
The sequencing format allowed us to identify IgG4-encoding
transcripts in 5 of 6 donors. IgG4-encoding sequences in general
used a larger number of IGHV genes, a wider distribution of
CDRH3 lengths, and mostly represented a larger number of
independent clones (Fig 1, D and E; see Tables E5 and E6) than
did the IgE-encoding repertoires of the same samples. The length
distribution of IgG4-encoding CDRH3, IGHV gene usage pattern,
and clonal composition of BM were also mostly well replicated
between biological duplicate samples (see Figs E3, E9 and E11
in this article’s Online Repository at www.jacionline.org),
suggesting that each BM sample adequately represented major
dominant features of the IgG4 repertoire. In contrast, such features
of the IgG4 repertoire were not as well reproduced in duplicate
samples of PB (see Figs E3, E9 and E11).
To assess the relationship of the IgE and IgG4-encoding tran-
scriptomes, both regulated in similar ways,6 and transcriptomes1
FIG 1. IgE repertoires encoded by cells in BM are more diverse than those encoded by cells in PB. IGHV
germline genes origins of IgE-encoding transcripts (present at >0.1%) found in duplicate samples of BM (A)
and PB (B) of 6 donors. Hierarchical clustering (C) of V gene usage percentages of 70 genes (Euclidean dis-
tances, average linkage) of duplicate samples encoding different isotypes (top boxes: IgA, black; IgE, or-
ange; IgG, green; IgM, red) in different tissues (middle boxes: PB, orange; BM, blue) as derived from
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between these repertoires. The analysis used the 50 most promi-
nent IgE clones and the entire set of sequences encoding other iso-
types. The algorithm used to assess the overlap between different
transcriptomes required that matching sequences originated in the
same IGHV gene (not considering allelic variation) and had the
same CDRH3 length but it allowed for up to 20% diversification
of CDRH3 at the nucleotide level, to minimize false negatives
caused by somatic hypermutation targeting CDRH3. Despite us-
ing these relaxed criteria, a very minor part (<0.2%) of the tran-
scriptomes encoding IgG4 (as well as those encoding IgA, IgG,
and IgM) in BM and PB showed evidence of clonal relatedness
to the IgE-encoding population. In fact, in most cases, no related
sequences were identified at all (see Fig E12 in this article’s On-
line Repository at www.jacionline.org). Altogether these findings
indicate that cells of BM, a major site of antibody production, and
PB of these subjects who have not undergone SIT mostly produce
IgE with no clonal relatedness to clones that encode other major
antibody isotypes.
SIT induces allergen-specific antibodies, often IgG4,
5 only
some of which (most likely those that target the same epitopes
as those bound by IgE) protect against allergen-mediated reac-
tions.7 We hypothesize, on the basis of present observations,
that immunotherapy that is able to exploit the same clonal rear-
rangements as those used for production of IgE also for produc-
tion of protective antibodies (eg, IgG4) will be particularly
successful in alleviating symptoms and in providing cure. We
therefore hypothesize that sequence-based analysis demon-
strating enhanced clonal overlap between IgE and IgG4 (or other
antibody isotypes/subclasses) may provide objective biomarkers
in the analysis of SIT efficacy.
Antibody-encoding gene sequences as such do not per se
define the specificity of an encoded antibody. Indeed, the vast
diversity of the immune repertoire suggests that the response
to a complex antigen composed of multiple epitopes, like a pro-
tein, will be diverse in terms of sequence. In several instances,
though, specific sequence features (stereotyped rearrangements)
are highly enriched in a given antigen-specific antibody
response.8 IgEs specific for grass pollen allergen Phl p 2 often
display a 10-residue long CDRH3 with glycin as the fifth resi-
due, and are encoded by genes originating from IGHV4-30-4 or
IGHV4-31 germline genes.9 When searching for such sequences
in the presently investigated transcriptomes, we identified 3 do-
nors of BM (donors 2, 3, 6) and 1 donor of PB (donor 3) whose
samples contained large frequencies of such IgE-encoding tran-
scripts (see Fig E13 in this article’s Online Repository at www.
jacionline.org). Such sequences were very rarely represented in
these subjects’ primary repertoires (transcripts encoding
unmutated IgM), and in IgG (Fig E13). Importantly, these 3 do-
nors, but not donors 1, 4, and 6, were also seropositive for Phl p
2–specific IgE (see Table E7 in this article’s Online Repository
at www.jacionline.org). In summary, there was a correspon-
dence between the presence of a particular rearrangement anddifferent donors (bottom boxes). Duplicate samples o
samples of these isotypes as derived from 1 donor co
the IgE-encoding repertoire derived from PB, and to so
clones encoding different isotypes identified in 10-mL s
the mean 6 1 SD of 2 duplicate biological samples coll
not contain IgE-encoding transcripts and IgG4-encodin
donor 5.
=the presence of allergen-specific, circulating IgE. This finding
sets the foundation for using antibody variable domain
sequences as objective biomarkers in those instances in which
stereotyped rearrangements can be associated with a specific
immune response. By greatly expanding our current small set
of human allergen-specific IgE,10 we envisage that we will
be able to identify additional stereotyped allergen-specific
IgE responses, signatures that will find use as biomarkers in
the future.
In conclusion, IgE repertoires of BM samples are more
diverse and more reproducible in their composition than those
of commonly sized PB samples. Samples from BM should
consequently be preferred over those from PB in future studies
of IgE and its sequence-based biomarkers. Studies of allergen-
specific antibodies of isotypes other than IgE must not a priori
be used to define the character of IgE because the degree of
overlap between these repertoires is very small. Furthermore,
we propose that there is a window of opportunity for NGS to
assist in the assessment of successful SIT, if such treatment is
able to induce a high degree of clonal overlap between IgE
and other isotypes, and the IgG4 subclass in particular. Finally,
we envisage that BM-encoded repertoires, through their larger
diversity, may also be an excellent source of IgE diversity for
the development of human monoclonal IgE through cellular
cloning or combinatorial library approaches,10 antibodies that
will enhance our understanding of IgE-allergen interactions
and their outcomes.
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